Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trial

Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trial

Abstract Background The high-risk refractory and/or relapsed (R/R) childhood acute leukemia prognosis is poor, and allogeneic stem cell transplantation (allo-HSCT) is the most prudent treatment modality. However, there are limited matched sibling donors (MSDs), and alternative donors (ADs) are the m...

Full description

Bibliographic Details
Main Authors: Binglei Zhang, Jian Zhou, Fengkuan Yu, Tianxin Lv, Baijun Fang, Dandan Fan, Zhenyu Ji, Yongping Song
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Experimental Hematology & Oncology
Subjects:
Prognosis
High-risk refractory and/or relapsed childhood acute leukemia
Allogeneic stem cell transplantation
Matched sibling donors
Alternative donors
Online Access:http://link.springer.com/article/10.1186/s40164-020-00162-6

Similar Items

Similar Items